Skip to main content

Day: December 18, 2025

Mobix Labs Reports Strong Fiscal 2025 Growth and Improved Operating Performance

Mobix Labs Expected to Deliver 54% Year-Over-Year Revenue Growth with Significant Margin Expansion and Reduced Operating Losses IRVINE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Mobix Labs, Inc. (“Mobix” or the “Company”) today announced selected preliminary, unaudited financial results for its fourth quarter and fiscal year ended September 30, 2025, highlighting strong year-over-year revenue growth, meaningful gross margin expansion, and improved operating performance. The preliminary financial information presented in this press release is based on information available to the Company as of the date of this release and remains subject to the completion of the Company’s year-end closing procedures and audit. Actual results may differ from these preliminary results, and such differences may be material. Final results will be reported...

Continue reading

Sezzle’s MoneyIQ Reaches One Million Lessons in Its First Year

The in-app gamified financial literacy program gains traction as users look to Sezzle as an all-in-one platform for shopping, rewards, and financial education. Minneapolis, MN, Dec. 18, 2025 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // – Sezzle, the leading purpose-driven Buy Now, Pay Later platform, today announced a major milestone for MoneyIQ, its in-app financial literacy program: more than one million lessons completed by over 200,000 users in less than a year. The milestone underscores Sezzle’s commitment to prioritizing users’ long-term financial well-being alongside flexible payments at checkout. By embedding financial education directly into the Sezzle app, and incentivizing users for their learning with Sezzle Spend, the Company is evolving BNPL into a platform designed to support users across...

Continue reading

Terra Innovatum Global Honored with Sustainability Special Mention at 2025 UNCA Awards

Terra Innovatum Global Recognized for Thought Leadership, Advancing Energy Equity, and Global Access to Clean Power Through its SOLO™ Micro-Modular Nuclear Reactor NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) — Terra Innovatum Global N.V. (“Terra Innovatum” or the “Company”) (NASDAQ: NKLR), a developer of micro-modular nuclear reactors today announced that it has been honored with a Special Mention for Sustainability at the 2025 United Nations Correspondents Association (UNCA) Awards Gala.Left to Right: Cesare Frepoli – Co-Founder & Chief Operating Officer at Terra Innovatum, Alessandro Petruzzi – Co-Founder & Chief Executive Officer at Terra Innovatum, Valeria Robecco – President at United Nations Correspondent Association (UNCA), Giordano Morichi – Founding Partner, Chief Business Officer &...

Continue reading

Cartier Reports Significant Gold Resource Growth At Cadillac With 9,953,000 tonnes at a grade of 2.40g/t Au for 767,800 Ounces Measured and Indicated, a 7% Increase and 35,185,000 tonnes at a grade of 2.14g/t Au for 2,416,900 Ounces Inferred, a 48% Increase

VAL-D’OR, Quebec, Dec. 18, 2025 (GLOBE NEWSWIRE) — Cartier Resources Inc. (″Cartier″ or the ″Company″) (TSXV: ECR; FSE: 6CA) is pleased to announce the results of the Updated Mineral Resource Estimate (“MRE”) on its 100% owned flagship Cadillac Project, located in Val-d’Or (Abitibi, Quebec). The updated estimates include approximately 110,000 metres of drilling completed by Cartier from 2016 to 2024 as well as 420,000 metres drilling completed by previous mining companies. The MRE was independently prepared by PLR Resources Inc. and Evomine, specialists in mineral resource estimates and project evaluations, in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”) and is dated December 17, 2025.  Strategic & Investment Significance Highlights of...

Continue reading

Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference

WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the J.P. Morgan 2026 Healthcare Conference, being held January 12 – 15 in San Francisco. Olivier Loeillot, President and Chief Executive Officer, will present an overview of the company on Tuesday, January 13 at 2:15 p.m. PT. A live webcast of the conference presentations will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event. About Repligen CorporationRepligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies...

Continue reading

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

Nature Medicine asked leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new treatments for advanced cancers and long COVID BriaCell’s Phase 3 clinical trial in metastatic breast cancer featured as “clinical trial to watch in 2026” BriaCell anticipates reporting top line data as early as H1-2026PHILADELPHIA and VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, is pleased to announce its Phase 3 Bria-IMT™ clinical trial in metastatic breast cancer has been prominently and independently featured in the Nature Medicine Year In Review’s publication, “Eleven clinical...

Continue reading

StorageVault to Acquire Six Assets for $71.8 Million, Exceeding $200 Million Completed and Announced Transactions for 2025

TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault”) (SVI-TSX) is pleased to announce that it has agreed to acquire six assets from five vendor groups (collectively, the “Vendors”) for an aggregate purchase price of $71.8 million, subject to customary adjustments and due diligence conditions (the “Acquisitions”). Four of the transactions are arm’s length, and one transaction consisting of two stores, totaling $42.0 million, is a related party acquisition (the “Related Party Acquisition”) with Access Self Storage Inc. and its affiliate (“Access”) as the Vendor. It is anticipated that the Acquisitions will close in Q1 2026. The assets are located in British Columbia, Alberta, Ontario and Quebec and are complementary to StorageVault’s existing portfolio. With the $132.6 million of completed year to date...

Continue reading

FuelCell Energy Ends FY2025 with Revenue Growth and a Focus on Data Center Opportunities

Fourth Quarter Fiscal 2025 Summary(All comparisons are year-over-year unless otherwise noted)Revenue of $55.0 million, compared to $49.3 million, an increase of approximately 12% Gross loss of $(6.6) million, compared to $(10.9) million, a decrease of approximately 39% Loss from operations of $(28.3) million, compared with $(41.0) million, a decrease of approximately 31% Net loss per share attributable to common stockholders was $(0.85), compared with $(2.21) Backlog of $1.19 billion, compared to $1.16 billion, an increase of approximately 2.6%Fiscal Year 2025 Summary(All comparisons are year-over-year unless otherwise noted)Revenue of $158.2 million, compared to $112.1 million Gross loss of $(26.4) million, compared to $(35.9) million Loss from operations of $(192.3) million, compared with $(158.5) million Net loss per share attributable...

Continue reading

DMG Blockchain Solutions Reports Fourth Quarter and Full Year 2025 Audited Results

VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a vertically integrated blockchain and data center technology company, today announces its fiscal fourth quarter and full year audited 2025 financial results. All financial references are in Canadian Dollars unless specified otherwise. Readers are encouraged to review the Company’s September 30, 2025 full year audited financial statements and management’s discussion and analysis thereof for an assessment of the Company’s performance and applicable risk factors, available at www.sedarplus.ca. Full Year 2025 Financial Results HighlightsRevenue: $47.3 million, up 40% from $33.9 million in 2024 Bitcoin Mined: 344 bitcoin with an ending balance of 342 bitcoin Hashrate: average 1.70 EH/s...

Continue reading

Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform

The combined Company will move forward as Decoy Therapeutics, Inc. and trade on the NASDAQ Stock Market under the ticker “DCOY” effective in early January 2026 Company to focus on advancing lead antiviral programs, expanding platform validation and achieving multiple data milestones Strategic 2026 roadmap designed to accelerate development, expand pipeline breadth, and drive long-term shareholder value HOUSTON, Dec. 18, 2025 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) today announced that in connection with its recent combination with Decoy Therapeutics Inc. (Decoy), the Company intends to change its corporate name to Decoy Therapeutics Inc. and its NASDAQ ticker symbol to DCOY. The planned name and ticker change mark a pivotal step in the Company’s transformation into a platform-driven biotechnology company...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.